solver.press

Integrating evolutionary trade-off models from antibiotic resistance studies with equilibrium concepts beyond unilateral deviation will identify coalition-driven resistance pathways that are otherwise inaccessible to standard fitness landscape analyses.

BiologyJun 6, 2026Evaluation Score: 63%

Adversarial Debate Score

60% survival rate under critique

Expert panel critique

Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.

ChatGPT: The hypothesis is clearly falsifiable and builds creatively on established concepts, but while the cited papers robustly support the centrality of trade-offs and fitness landscapes in resistance, direct evidence for coalition-driven (multi-agent or coordinated) resistance pathways and the practic...
Mistral: The hypothesis is falsifiable and builds logically on cited trade-off and equilibrium concepts, but its novelty and empirical support remain unproven; coalition-driven pathways are speculative without direct evidence in the provided excerpts.
Gemini: The hypothesis is falsifiable and introduces a novel integration, but the provided
Grok: The hypothesis links two paper-supported domains (trade-off costs in resistance; coalitional equilibria) but offers no evidence or mechanism showing their integration reveals otherwise inaccessible pathways, rendering it speculative and weakly falsifiable.

Supporting Research Papers

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Integrating evolutionary trade-off models from antibiotic resistance studies with coalition-based equilibrium concepts (i.e., Nash equilibria permitting coordinated, multi-genotype deviations) will reveal coalition-driven resistance pathways in microbial fitness landscapes that cannot be detected by standard models limited to unilateral deviations.

Disproof criteria:
  • No coalition-driven resistance pathways are found that are inaccessible to standard unilateral deviation analyses.
  • Coalition-based models fail to improve predictive accuracy for resistance evolution compared to standard approaches.
  • Empirical validation fails: predicted coalition-driven pathways are not observed in real or simulated data.
  • Integration of coalition-based equilibria into trade-off models does not yield statistically significant new insights (ΔAUC < 0.02 versus baseline).

Spine & Adversarial ReadReady for validation

Integrating coalition-based equilibrium concepts into evolutionary trade-off models of antibiotic resistance uncovers resistance pathways inaccessible to standard unilateral analyses.

  • highCoalition-based deviations may not represent biologically plausible evolutionary events in microbial populations, as simultaneous multiple mutations are exceedingly rare.
    The methodology limits coalition size to k=2–3 and requires empirical validation in real datasets; if coalition pathways are not observed, the hypothesis will be falsified.
  • mediumThe choice of datasets and models (e.g., E. coli, β-lactamase) may not generalize to other microbes or resistance mechanisms.
    The EVP specifies extensibility to other datasets; initial validation focuses on well-characterized systems for feasibility.
  • mediumWhy use coalition equilibria rather than alternative multi-locus evolutionary models (e.g., epistasis-aware Markov models)?
    Coalition equilibria expressly model coordinated, not merely interacting, deviations; this approach is justified by the hypothesis but could be compared against other models in future work.

Experimental Protocol

  1. Select a model organism with well-characterized antibiotic resistance evolution (e.g., Escherichia coli).
  2. Obtain a high-resolution fitness landscape constructed from combinatorial resistance genotypes (e.g., from deep mutational scanning datasets).
  3. Construct two predictive models: a. Baseline: Evolutionary trade-off model using standard fitness landscape analysis (unilateral deviations only). b. Experimental: Integrate coalition-based equilibrium concepts (e.g., Strong Nash equilibria) into the trade-off model.
  4. Simulate evolutionary trajectories under both models, tracking accessible resistance pathways.
  5. Empirically validate model predictions using (a) historical laboratory evolution data, and (b) time-resolved clinical isolate datasets.
  6. Quantitatively compare the pathways identified by each model, and assess empirical overlap.
Required datasets:
  • Deep mutational scanning data for resistance genes (e.g., β-lactamase in E. coli; see Stiffler et al., 2015, Cell).
  • Longitudinal laboratory evolution datasets (e.g., LTEE, Pseudomonas/E. coli resistance evolution).
  • Clinical isolate resistance genotype/phenotype datasets (e.g., NCBI Pathogen Detection Project).
  • Standard fitness landscape representations, e.g., genotype × fitness matrices.
Success:
  • The coalition-based model identifies at least one resistance pathway per dataset not found by the unilateral model.
  • Empirical validation shows that ≥20% of coalition-driven pathways are observed in real evolution data, compared to ≤5% for random or baseline models.
  • Predictive accuracy (AUC or recall for resistance endpoint prediction) is improved by ≥0.02 over baseline.
  • Statistical significance of improvement p < 0.05.
Failure:
  • No additional pathways identified by coalition-based model.
  • Empirical validation rate of coalition-driven pathways does not exceed random expectation (p ≥ 0.05).
  • No statistically significant improvement in predictive accuracy.
  • Model fails to converge or is computationally infeasible for the chosen landscape.

80

GPU hours

60d

Time to result

$3,200

Min cost

$9,000

Full cost

ROI Projection

Commercial:
  • High for pharmaceutical R&D (antibiotic pipeline prioritization, resistance forecasting).
  • Valuable for public health surveillance (improved prediction of resistance emergence).
  • Research tool for evolutionary biology and computational genomics fields.

Implementation Sketch

# High-level pseudocode/architecture for experimental validation

# 1. Setup
import numpy as np
from coalition_equilibrium import compute_strong_nash, coalition_enumerate
from fitness_landscape import load_fitness_matrix, simulate_evolution
from validation_utils import match_paths, roc_auc_score

# Load datasets
fitness_matrix = load_fitness_matrix('beta_lactamase_DMS.csv')
lab_trajs = load_lab_evolution_data('lab_evolution.csv')
clinical_trajs = load_clinical_data('clinical_isolates.csv')

# 2. Baseline Model: Unilateral Deviations
def find_unilateral_paths(fitness_matrix, start_genotype, end_genotype):
    # Greedy ascent: only single-mutation steps
    paths = []
    for path in hill_climb_paths(fitness_matrix, start_genotype, end_genotype, max_steps=10):
        paths.append(path)
    return paths

# 3. Coalition Model: Multi-genotype deviations
def find_coalition_paths(fitness_matrix, start_genotype, end_genotype, max_coalition_size=3):
    # Enumerate all k-tuple mutations (k = 2,3) at each step
    coalition_paths = []
    for coalition in coalition_enumerate(fitness_matrix, start_genotype, end_genotype, max_k=max_coalition_size):
        if compute_strong_nash(fitness_matrix, coalition):
            coalition_paths.append(coalition)
    return coalition_paths

# 4. Simulation Loop
results = []
for start_genotype in representative_starting_points(fitness_matrix):
    unilat_paths = find_unilateral_paths(fitness_matrix, start_genotype, target_resistance_genotype)
    coal_paths = find_coalition_paths(fitness_matrix, start_genotype, target_resistance_genotype)
    results.append({'start': start_genotype, 'unilat': unilat_paths, 'coal': coal_paths})

# 5. Validation Against Empirical Data
def validate_paths(predicted_paths, empirical_trajs):
    match_rate = match_paths(predicted_paths, empirical_trajs)
    auc = roc_auc_score(predicted_paths, empirical_trajs)
    return match_rate, auc

unilat_match, unilat_auc = validate_paths([r['unilat'] for r in results], lab_trajs + clinical_trajs)
coal_match, coal_auc = validate_paths([r['coal'] for r in results], lab_trajs + clinical_trajs)

# 6. Statistical Analysis
improvement = coal_auc - unilat_auc
significant = permutation_test(coal_auc, unilat_auc, n=1000, alpha=0.05)

# 7. Output
print(f"Unilateral AUC: {unilat_auc}, Coalition AUC: {coal_auc}, Improvement: {improvement}, Significant: {significant}")

# All code, environments, and data are archived for reproducibility.

# Controls:
# - Randomized path generation as a negative control.
# - Bootstrapped sampling to assess robustness.

# Output artifacts:
# - Tables of identified pathways (with overlap/novelty scores)
# - Validation metrics (AUC, recall, p-values)
# - Code archive and parameter log
Abort checkpoints:
  • After data prep: abort if <1,000 non-redundant genotypes available.
  • After baseline modeling: abort if no difference in pathway count between models.
  • After empirical validation: abort if match rate for coalition pathways ≤ random expectation.

Source

AegisMind Research
Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started